search
Advanced Medicine
Trends
- 1
Health outlets are highlighting an mRNA vaccine being developed for melanoma, the deadliest form of skin cancer. The approach uses the same mRNA technology proven in COVID-19 vaccines, training the immune system to recognize and attack tumor cells. WVU Medicine shared the update, and the item is drawing attention as trials of personalized cancer vaccines continue to advance globally.
- 2Study Finds Proliferative Pause Could Help Prevent Brain Metastasis▼Proliferative Pause Reveals Window to Prevent Brain Metastasis
Researchers report that a 'proliferative pause' — a dormant phase cancer cells enter before spreading — may offer a critical window to intervene and stop brain metastasis before it takes hold. The findings, covered by Inside Precision Medicine, suggest targeting cells during this quiet period could prevent secondary brain tumours, a major cause of death in patients with advanced cancers such as breast cancer and melanoma.
- 3Mandatory Ambulatory Specialty Model Advances Despite Physician Opposition▼Mandatory Ambulatory Specialty Model Moves Ahead Despite Medicine’s Concerns
A mandatory ambulatory specialty payment model is moving forward, according to the Texas Medical Association, which notes that the physician community continues to raise concerns about its design and impact on medical practices. Doctors' groups worry the model could constrain how specialists deliver outpatient care, even as regulators proceed with implementation despite calls from medicine to slow down or revise it.
- 4Penn Medicine and IBA Launch Proton Therapy Joint Venture▼Penn Medicine, IBA Form Joint Venture to Advance Proton Therapy, Radiation Oncology
Penn Medicine and Belgian medical technology company IBA have formed a joint venture aimed at advancing proton therapy and radiation oncology. The partnership will combine Penn Medicine's clinical expertise with IBA's technology to develop and expand proton therapy treatments for cancer patients.
- 5
A New York Times opinion piece argues that artificial intelligence is set to transform medical practice and training fundamentally. It examines how AI tools are changing what doctors do and how medical students should be educated for a profession that will look very different from previous generations. Readers are debating how soon AI will reshape diagnosis, documentation, and the role of the physician.
- 6Weill Cornell gets $3M for HIV brain research center▼Weill Cornell receives $3M to launch research center for HIV’s effects on brain
Weill Cornell Medicine has received $3 million to establish a new research center focused on how HIV affects the brain. The funding will support studies into the neurological effects of the virus, an area that remains underexplored even as antiretroviral therapy has extended the lives of people living with HIV. Researchers hope the center will advance understanding of HIV-related cognitive decline and lead to better treatments for affected patients.
- 7Former Pfizer Executive Bill Sessa Named Chair of Isomab Advisory Board▼Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board
Professor Bill Sessa, formerly Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The move gives the biotech company a senior figure with decades of large-pharma experience as it advances its scientific programmes, and the announcement was distributed via PR Newswire.
- 8
Yale Medicine reports that new treatment approaches for head and neck cancer are leading to better outcomes for patients. Advances highlighted include refined therapies aimed at improving survival and quality of life. The update is drawing attention as clinicians and patient communities follow progress in one of the more challenging cancer areas.
- 9Scientists refine targeting of cell-surface proteins▼Targeting cell-surface proteins with greater precision
News-Medical reports on advances allowing researchers to target cell-surface proteins with greater precision, a development relevant to drug delivery and therapeutic design. Cell-surface proteins are key entry points for medicines, so improved targeting accuracy could mean more effective treatments with fewer side effects. The report has drawn attention from readers following progress in biotechnology and molecular medicine.
- 10Anthropic joins ARPA-H clinical AI moonshot●Anthropic joins ARPA-H clinical AI moonshot, will hold closed-door health care event
Anthropic has joined ARPA-H's clinical AI moonshot program and will host a closed-door event focused on health care applications of artificial intelligence. The partnership signals growing involvement of major AI companies in US government-backed medical research, as health agencies push to bring advanced AI tools into clinical settings.
- 11Wiley launches Advanced Medicine and Advanced Healthy Aging journals●Wiley launches two new research journals—Advanced Medicine and Advanced Healthy Aging—Continuing expansion of its Advanced Portfolio
Publisher Wiley has announced the launch of two new peer-reviewed research journals, Advanced Medicine and Advanced Healthy Aging, extending its existing Advanced journal portfolio. The move targets fast-growing areas of clinical and aging research, where output and funding continue to expand. The announcement was made via a science news release, with details on scope, editorial leadership and open-access terms expected from the publisher.
- 12Cancer vaccine puts terminal patient into remission▼Exclusive | She was ready to die. Now she’s in remission — cancer vaccines could be the next big thing in medicine
A woman who had been prepared to die has entered remission after receiving an experimental cancer vaccine, in a report highlighting the technology as a possible next major advance in medicine. The case is being presented as evidence that therapeutic vaccines, which train the immune system to attack tumors, could transform cancer treatment.
- 13US Army Officer Advances Medical AI Collaboration●LTC Kirkwood Advances Medical AI Collaboration through Engineer and Scientist Exchange Program
Lieutenant Colonel Kirkwood of the Uniformed Services University is advancing collaboration on medical artificial intelligence through the Engineer and Scientist Exchange Program. The initiative connects military researchers with partner-nation scientists to share expertise in AI applications for healthcare and medicine, strengthening international research ties in military medical technology.
- 14Aptadir raises €40M to advance demethylating medicines●Aptadir has €40M warchest to advance demethylating medicines
Spanish biotech Aptadir has secured a €40 million funding package to advance its demethylating medicines, a class of therapies targeting epigenetic changes in cancer cells. The company says the new capital will support development of its pipeline of epigenetic drug candidates as it moves toward clinical progress.